All articles by Linda Stewart – Page 136
-
NewsPotential nasal COVID-19 vaccine candidate offers better and longer protection
Study shows that administering a COVID-19 vaccine as a nasal spray rather than a subcutaneous injection enhances the body’s long-term immune memory, thereby increasing the vaccine’s overall effectiveness.
-
NewsPhages pay heavy price for environmental intel - but it’s worth it
Phages, the viruses that infect bacteria, will pay a high growth-rate cost to access environmental information that can help them choose which lifecycle to pursue, according to a study. Source: L. F. Lee; J. A. Boezi Bacteriophage gh-1 for Pseudomonas putida. Yigal Meir and colleagues at Ben-Gurion ...
-
NewsAI platform for wastewater plants harnesses microbiome and engineering data
Scientists have introduced a groundbreaking Global WWTP Microbiome-based Integrative Information Platform to address the escalating complexities of pollutants and inadequacies in traditional wastewater treatment plants.
-
NewsValneva vaccinates first participant in pediatric trial of single-shot Chikungunya vaccine
Valneva SE has announced that the first participant has been vaccinated in the Phase 2 clinical trial evaluating the safety and immunogenicity in children of two different dose levels of Valneva’s single-shot chikungunya vaccine.
-
NewsMicroplastics affect soil fungi depending on drought conditions
Moisture levels in the soil can impact the effects that microplastic pollution has on soil fungi, according to new research published in Environmental Microbiology, an Applied Microbiology International publication.
-
NewsHigher viral load during HIV infection can shape viral evolution
A new paper finds that HIV populations in people with higher viral loads also have higher rates of viral recombination.
-
NewsPredominantly plant-based or vegetarian diet linked to 39% lower odds of COVID-19
A predominantly plant-based or vegetarian diet is linked to 39% lower odds of COVID-19 infection, finds new research.
-
NewsCrop spray could lead to mass resistance in new-generation antifungal treatments
An agricultural fungicide approved in the US and currently under consideration by authorities worldwide could have a devastating effect on a new drug for one of world’s deadliest infectious diseases.
-
NewsVaccine boosts innate immunity in people with dormant immune cells
Epigenetic cell states predict whether or not an individual profits from the “wake-up call” to the innate immune system that is provided by the BCG vaccine.
-
NewsZika virus is effective when used to treat a type of childhood cancer in mice
Injecting neuroblastoma tumors with Zika virus shrank or eliminated those tumors in studies with mice, suggesting that the virus could someday serve as an effective cancer therapy, according to a new study.
-
NewsNovo Nordisk Foundation partners with CARB-X to fight drug-resistant infections
The Novo Nordisk Foundation is committing up to $25 million to support the early-stage development of innovative tools to prevent, diagnose and treat the most dangerous drug-resistant bacterial infections. The three-year grant will go to the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), the leading global non-profit public-private partnership in this ...
-
NewsNaturally occurring pathogenic fungi recruited to control Eucalyptus snout beetle
Scientists have found naturally occurring pathogenic fungi infecting the Eucalyptus snout beetle in Eucalyptus forest plantations, and characterised them to develop a bio-pesticide for controlling the beetle.
-
NewsScientists reveal why chicken farms are a breeding ground for AMR bacteria
Scientists are one step closer to understanding how bacteria, such as E. coli and Salmonella enterica, share genetic material which makes them resistant to antibiotics.
-
NewsMore than 30 new species of bacteria discovered in patient samples
A team that has been collecting and analyzing patient samples containing unknown germs since 2014 have discovered more than 30 new species of bacteria, some of which are associated with clinically relevant infections.
-
![RW703786[46]](https://d3rmrttq0bsnxi.cloudfront.net/Pictures/100x67/4/2/2/5422_rw70378646_994081.jpg)
NewsFA Bio secures £5.3m investment from Clean Growth Fund, Pymwymic and Ship2B Ventures
FA Bio, the British bio-tech company, has secured a £5.3 million tranche of investment from three European venture capital investment funds as well as existing shareholders and new private investors.
-
NewsSmart skin bacteria able to secrete and produce molecules to treat acne
An experimental study has shown that a type of skin bacterium can efficiently be engineered to produce a protein to regulate sebum production.
-
NewsBioExcel-CV19 offers breakthrough in understanding COVID-19 proteins
Designed to meet the urgent need for insights into the molecular intricacies of SARS-CoV-2 infection, BioExcel-CV19 is a repository for Molecular Dynamics (MD) simulations.
-
NewsIntravaginal sponge can make candidiasis treatment more comfortable and effective
A biodegradable sponge made of chitosan, a biopolymer derived from the shells of crustaceans, releases medication slowly into the organism and makes treatment of candidiasis more comfortable and effective.
-
NewsResearchers uncover how molecular freight elevators work in pathogenic bacteria
Researchers studying bacterial membrane transporters have studied the interaction between the transporter and its soluble substrate binding protein, showing that they adapt precisely to each other during the transportation process.
-
NewsGut bacteria combinations protect stem cell transplantation patients from dangerous immune reactions
Researchers have shown that graft versus host disease (GvHD) is less common when certain microbes are present in the gut. In the future, it may be possible to deliberately bring about this protective composition of the microbiome.